Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2007
10/04/2007US20070231338 Production and Use of the Methotrexate-Albumin Conjugate as an Immunosuppressive Agent in Gvhd
10/04/2007US20070231270 Biopolymer and Gene Complex
10/04/2007US20070231269 Analgesics
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007US20070231261 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers
10/04/2007DE10262176B4 Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung Process for the preparation of antibiotically coated porous bodies as well as use of
10/04/2007DE10227935B4 Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung A process for preparing a antibiotic coating of porous bodies, and using
10/04/2007DE102006014296A1 Verfahren zur Acylierung von Cholinchlorid, Fettsäurecholinsalzester und deren Verwendung Process for the acylation of choline chloride, Fettsäurecholinsalzester and their use
10/04/2007CA2646349A1 Storage of influenza vaccines without refrigeration
10/04/2007CA2623561A1 Gelling hydrophobic injectable polymer compositions
10/04/2007CA2583978A1 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
10/03/2007EP1839676A2 Erythropoietin derivates
10/03/2007EP1839673A2 Prevention and treatment of hypergastrinemia
10/03/2007EP1839670A2 Modified Annexin Proteins and Methods for preventing Thrombosis
10/03/2007EP1839665A1 Intraoral disintegration type solid preparation containing povidone iodine
10/03/2007EP1839651A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
10/03/2007EP1839650A1 Quick disintegration tablet and method of producing the same
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1839643A1 Cosmetic and pharmaceutical foam carrier
10/03/2007EP1839499A1 Composition composed of highly dispersible cellulose complex and polysaccharide
10/03/2007EP1838736A2 Cripto binding molecules
10/03/2007EP1838734A2 Antibodies against antigen presenting cells and uses thereof
10/03/2007EP1838664A1 Manufacture process of n-substituted salicylamides
10/03/2007EP1838317A1 Analgesic conjugates
10/03/2007EP1838307A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers
10/03/2007EP1838290A2 Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
10/03/2007EP1740214B1 Method of stabilizing disordered cefovecin sodium salt
10/03/2007EP1704160A4 Methods and compositions for identifying rna-binding proteins
10/03/2007EP1654289B1 Polysialic acid derivatives
10/03/2007EP1558219B1 Pharmaceutical formulation of olanzapine
10/03/2007EP1455763B1 Oral capsule formulation with increased physical stability
10/03/2007EP1453909B1 Cereal beta glucan compositions, methods of preparation and uses thereof
10/03/2007EP1439828A4 Veterinaire florfenicol formulation that is syringeable under cold weather conditions
10/03/2007EP1436011B1 Dendrimers for use in targeted delivery
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1337285B1 Implants with a phosphazene-containing coating
10/03/2007EP1267839B1 Microspheres for active embolization
10/03/2007EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
10/03/2007EP1232182B1 Bovine collagen and method for producing recombinant gelatin
10/03/2007EP1044013B9 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
10/03/2007EP0735896B1 Parathyroid hormone formulation
10/03/2007EP0563093B2 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/03/2007CN101048180A Solid formulation with improved solubility and stability, and method for producing said formulation
10/03/2007CN101048179A Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
10/03/2007CN101048174A Composition comprising vlp and amyloid-beta peptide
10/03/2007CN101048164A Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
10/03/2007CN101048155A Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent for enhanced absorption
10/03/2007CN101045166A Pulmonary administration of chemically modified insulin
10/03/2007CN101045165A Hydroxypropyl beta-cyclodextrin clathrate of astaxanthin, and its preparing method
10/03/2007CN101045164A Double-chain structured polyethylene active derivatives, and ligature with other molecules
10/03/2007CN101045163A High molecular anticarcinogenic prodrug, its preparing method and use
10/03/2007CN101045162A Method for preparing medicine carryed nanometer particle of polycyanoacrylate
10/03/2007CN101045160A Hydrophobic agent used for target treatment to tumor blood vessel, its preparing method and use
10/03/2007CN101045156A Special target medicine and its use
10/03/2007CN101045154A Method for preventing traditional Chinese medicine extract powder from being moisture absorption
10/03/2007CN101045083A Qingxuan soft capsule for clearing giddiness, its preparing method and quality control method
10/03/2007CN101045067A 纳米生物导弹 Nanobiotechnology missile
10/03/2007CN101045062A Polyenephophatidylcholine enteric coated preparation, its preparing method and application
10/03/2007CN101045059A Anticarcinogen composition carried with both nitrosourea type medicine and guanine analog
10/03/2007CN101045058A Anticarcinogen composition containing alkylating agent and hormones medicines
10/03/2007CN101045056A Eyedrops for treating glaucoma and its preparing method
10/03/2007CN101045044A Thipronin enteric-coated delayed-release agent
10/03/2007CN101045041A Cataplasma containing ibuprofen its preparing method and application
10/03/2007CN101045040A Wrapped tablets dichlororeytadin and its preparing method
10/03/2007CN101045038A Process for preparing gallo lactone freeze-dried powder injection with good solubility
10/03/2007CN101045037A Cationic elaioplast and its adenovirus composition, its preparing method and use
10/03/2007CN101045036A Delayed-release injection containing nitrous carbamide type medicine and topographic enzyme inhibitor
10/03/2007CN101045035A Anticancer composite carried with tyrosine kinase inhibitor and phosphoinositide 3-kinase inhibitor
10/03/2007CN101045034A Bioadhesive drug delivery system
10/03/2007CN101045033A Ply-glycosyl modified acid-sensitive nanometer gel
10/03/2007CN101045032A Novel stop blooding and anti water seeping gel
10/03/2007CN100340668C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
10/03/2007CN100340599C Nano granule of polylysine amylum and its preparation method as well as application gene carrier
10/03/2007CN100340578C Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340291C F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy
10/03/2007CN100340289C Method to enhance an immune response of nucleic acid vaccination
10/03/2007CN100340250C Composite propolis soft capsule
10/03/2007CN100340240C Flunarizine hydrochloride lyophilized agent for injection and its preparing method
10/03/2007CN100340237C Transdermal drug delivery system with improved water absorbability and adhesion properties
10/02/2007US7276641 Mixture with analgesic and anti-inflammatory dissolved in an aqueous hot melt type adhesive base material of styrene-isoprene-styrene block copolymer, adhesive resin, an antioxidant, lanolin, and water; drug releasability, good bioavalability
10/02/2007US7276594 Nucleic acid-containing complex
10/02/2007US7276579 Immunogenic proteoliposomes, and uses thereof
10/02/2007US7276537 Formulations of anthraquinone derivatives
10/02/2007US7276499 Sulfur-containing taxanes, specially covalently bonded to a cell binding agent for targeted delivey to specific cell populations
10/02/2007US7276497 Cytotoxic agents comprising new maytansinoids
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276473 Combination of pancreatic cell surface marker binding agent, polypeptide translocation transfer element and enzymatic secretion inhibitor
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276254 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
10/02/2007US7276252 Material handling of toxic drugs; multilayer forms
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007CA2449244C Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
10/02/2007CA2271623C Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
10/02/2007CA2261887C Covalent polar lipid conjugates with biologically-active compounds for use in salves
10/02/2007CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
09/2007
09/27/2007WO2007109584A1 Temperature-and ph-responsive polymer compositions
09/27/2007WO2007109567A1 Anti-tat226 antibodies and immunoconjugates
09/27/2007WO2007109530A1 Cyclosporin a compositions
1 ... 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 ... 1712